PurposePancreatic cancer is the 4th most common cause of cancer death in Japan and exhibits a 5-year overall survival rate of approximately 7%. The accurate diagnosis of pancreatic cancer is important for determining the optimal management strategy. Fludeoxyglucose-positron emission tomography (FDG PET) integrated with computed tomography (18F-FDG PET/CT) has emerged as a powerful imaging tool for detecting and evaluating various cancers, and it is used for staging, detecting local recurrence and distant metastasis, measuring therapeutic effects, and predicting prognosis in pancreatic cancer patients. Lately, FDG PET/CT-derived parameters, such as standardized uptake values (SUV), the metabolic tumor volume (MTV), and total lesion glycolysi...
Purpose : To assess the role of coregistered 18F-fluorodeoxyglucose positron emission tomography (FD...
The aim of this study is to evaluate the effect of 18FDG PET on preoperative staging and clinical ma...
Abstract:ObjectiveFDG-PET provides quantitative information regarding the tumor glucose metabolism w...
Purpose Pancreatic cancer is the 4th most common cause of cancer death in Japan and exhibits a 5-ye...
Background: Pancreatic cancer is the tenth most prevalent cancer in world, and represents the fourth...
The prediction of survival of patients with pancreatic cancer is usually based on tumor staging and ...
In this study, we aimed to assess the prognostic value of metabolic tumor volume (MTV) and total les...
[Objective] FDG-PET/CT has been reported to be of prognostic value for pancreaic cancer. However, fe...
Objective: This phase-I imaging study examined the imaging characteristic of 3’-deoxy-3’-(18F)-fluor...
Objectives: FDG-PET provides quantitative information regarding the tumor glucose metabolism which i...
[Objective] FDG-PET/CT has been reported to be of prognostic value for pancreaic cancer. However, fe...
OBJECT:The histopathological grade of differentiation is one of the significant prognostic factors i...
Objectives: Fluorodeoxyglucose (FDG)-positron emission tomography/contrast-enhanced computed tomogra...
Aim The aim of this retrospective multicentre study was to evaluate the clinical and prognostic effe...
PURPOSE: We investigated the prognostic role of volume-based parameters measured on 18F-fluorodeoxy...
Purpose : To assess the role of coregistered 18F-fluorodeoxyglucose positron emission tomography (FD...
The aim of this study is to evaluate the effect of 18FDG PET on preoperative staging and clinical ma...
Abstract:ObjectiveFDG-PET provides quantitative information regarding the tumor glucose metabolism w...
Purpose Pancreatic cancer is the 4th most common cause of cancer death in Japan and exhibits a 5-ye...
Background: Pancreatic cancer is the tenth most prevalent cancer in world, and represents the fourth...
The prediction of survival of patients with pancreatic cancer is usually based on tumor staging and ...
In this study, we aimed to assess the prognostic value of metabolic tumor volume (MTV) and total les...
[Objective] FDG-PET/CT has been reported to be of prognostic value for pancreaic cancer. However, fe...
Objective: This phase-I imaging study examined the imaging characteristic of 3’-deoxy-3’-(18F)-fluor...
Objectives: FDG-PET provides quantitative information regarding the tumor glucose metabolism which i...
[Objective] FDG-PET/CT has been reported to be of prognostic value for pancreaic cancer. However, fe...
OBJECT:The histopathological grade of differentiation is one of the significant prognostic factors i...
Objectives: Fluorodeoxyglucose (FDG)-positron emission tomography/contrast-enhanced computed tomogra...
Aim The aim of this retrospective multicentre study was to evaluate the clinical and prognostic effe...
PURPOSE: We investigated the prognostic role of volume-based parameters measured on 18F-fluorodeoxy...
Purpose : To assess the role of coregistered 18F-fluorodeoxyglucose positron emission tomography (FD...
The aim of this study is to evaluate the effect of 18FDG PET on preoperative staging and clinical ma...
Abstract:ObjectiveFDG-PET provides quantitative information regarding the tumor glucose metabolism w...